Avior Wealth Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-29	Closed	-$5.35K	–	1080
2024 Q4	$5.35K	Buy	+29	New	+$5.59K	﹤0.01%	1835
2024 Q2	–	Sell	-483	Closed	-$131K	–	2591
2024 Q1	$131K	Buy	+483	New	+$115K	0.01%	852
2022 Q2	–	Sell	-527	Closed	-$129K	–	1089
2022 Q1	$149K	Hold	527	–	–	0.01%	464
2021 Q4	$198K	Hold	527	–	–	0.02%	431
2021 Q3	$217K	Sell	527 -25	-5%	-$10.4K	0.02%	411
2021 Q2	$204K	Sell	552 -3,375	-86%	-$1.13M	0.02%	400
2021 Q1	$1.14M	Sell	3,927 -473	-11%	-$131K	0.12%	158
2020 Q4	$1.1M	Buy	4,400 +368	+9%	+$87.6K	0.14%	141
2020 Q3	$913K	Sell	4,032 -260	-6%	-$54K	0.13%	147
2020 Q2	$748K	Buy	4,292 +2,022	+89%	+$323K	0.12%	163
2020 Q1	$286K	Hold	2,270	–	–	0.06%	280
2019 Q4	$346K	Hold	2,270	–	–	0.06%	294
2019 Q3	$300K	Buy	2,270 +410	+22%	+$55K	0.05%	300
2019 Q2	$264K	Sell	1,860 -350	-16%	-$47.5K	0.05%	319
2019 Q1	$321K	Buy	2,210 +720	+48%	+$94.6K	0.07%	264
2018 Q4	$168K	Buy	+1,490	New	+$187K	0.04%	345